The NHS in England is to introduce a new drug expected to help the majority of patients resistant to treatment for graft versus host disease (GvHD), it has been announced.
NHS England hopes the introduction of belumosudil will help 75% of the 200...
1 month ago
A newly designed T cell engager antibody could become an effective treatment for patients with acute myeloid leukaemia (AML) who do not qualify for stem cell transplants, researchers have reported.
The treatment aims to counter the effects of the...
1 month ago
